The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47.
Fastenal
FAST · a US exchange · USD · Market cap $57.8B · 21,763 employees
Fastenal Company, together with its subsidiaries, engages in the wholesale distribution of industrial and construction supplies in the United States, Canada, Mexico, and internationally.
PASS · Titan Ethical · score 89.0Price as of 27 Oct 2026Daily close, not a live quote
Screened 2026-10-27 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price51.55 USD at the 27 Oct 2026 close
- Our ratingOvervalued, current read accumulation
- Ethical screenPasses, score 89.0 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.18)
- Last reviewed27 Oct 2026 (1 days ago)
A summary of the dated readings below, not a live quote and not advice.
What this means: price 51.55 against the desk's fair-value range, base estimate 39.08, over the last year.
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning political buying, disclosed 2026-09-04
- Options put/call open interest 0.18, read 2026-10-27
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Fastenal holds its Accumulation at $51.55. The statistical read favours the sellers, held for 115 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 115 days |
| Price at the screen | $51.55 |
| Valuation | 42.69 trailing · 35.77 forward price to earnings |
| Values screen | PASS · score 89.0 |
| Beta | 0.69 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 8.75% | Below 33% | Interest-bearing debt is just 8.7% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 30.12% | Below 49% | Money owed to the company is 30.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.07% | Below 5% | Only 0.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Fastenal clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 9%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when FAST's ethical verdict changes
Today FAST passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads OVERVALUED: it trades above our $39.08 fair value estimate, moderate competitive moat, 15.50% revenue growth.
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. The price runs 22.4% above the base estimate.
Third-party analyst targets: 13 covering, consensus Hold. The average target sits −3% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFastenal Trades Rich Despite Solid Industrial Reach
Picture a factory floor where every fastener and fitting arrives without delay through Fastenal's tight distribution network across North America and beyond. The business delivers 15% revenue growth, 15% profit margins and a 34% return on equity with a moderate moat that keeps customers coming back.
Yet the shares change hands at 32.5 times forward earnings, 19% above our fair value. Analyst targets cluster around the current price with a consensus hold rating, so the valuation already prices in the strengths and leaves little room for error.
Industrial spending can drop sharply when cycles turn, and a moderate moat offers limited defence against bigger rivals. The ethical screen passes but the price does not. Analysis, not advice.
| Forward P/E | 35.8xexpensive even after accounting for its growth |
| Trailing P/E | 42.7xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 1.18 |
| EPS, forward | 1.41 |
| Revenue growth | +15.5%steady growth |
| Profit margin | 15.6%healthy profit margins |
| Return on equity | 35.3%an exceptional return on shareholder capital |
| FCF yield | 1.59% |
| Dividend yield | 2.09% |
| Debt to equity | 0.11minimal debt: a conservative balance sheet |
| Current ratio | 3.93comfortably covers its short-term bills |
| Beta | 0.69steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 38.97 - 52.92 |
| Moat | MODERATE |
| Market cap | $57.8B |
| Employees | 21,763 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFAST trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.5% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47.
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (12 analysts) rates it hold, with a mean price target of $47.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results Yahoo Finance · 1d ago
- Can Grainger Stock Repeat Its Last Five Years? Yahoo Finance · 2d ago
- Is Berkshire Bending the Rules With Bending Spoons? Yahoo Finance · 4d ago
- Fastenal (FAST) Earnings Put Its Valuation Back In Focus Yahoo Finance · 4d ago
- Does AI Data Center Demand Change The Bull Case For Fastenal (FAST)? Yahoo Finance · 4d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-24 | ANCIUS MICHAEL J | Director | 1,000 | $44,900 | |
| 2026-03-05 | WISECUP REYNE KAY | Director | 36,920 | $479,960 | |
| 2026-03-05 | WISECUP REYNE KAY | Director | 36,920 | $1,747,922 | |
| 2026-01-23 | SATTERLEE SCOTT ALAN | Director | 15,964 | $303,316 | |
| 2026-01-23 | SATTERLEE SCOTT ALAN | Director | 15,964 | $705,454 | |
| 2025-12-12 | ANCIUS MICHAEL J | Director | 1,500 | $63,015 | |
| 2025-11-19 | NIELSEN SARAH N | Director | 1,000 | $39,600 | |
| 2025-11-18 | ANCIUS MICHAEL J | Director | 2,000 | $27,500 | |
| 2025-11-17 | JOHNSON DANIEL L. | Director | 1,000 | $40,440 | |
| 2025-11-13 | HSU HSENGHUNG SAM | Director | 1,000 | $40,750 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-04 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-04 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-07-20 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $43.30 | +6.4% | · | $1,064 | +6.4% |
| 2 months | $48.91 | -5.8% | $0.24 | $947 | -5.3% |
| 3 months | $45.01 | +2.4% | $0.24 | $1,029 | +2.9% |
| 6 months | $41.30 | +11.6% | $0.48 | $1,128 | +12.8% |
| 1 year | $41.84 | +10.1% | $0.92 | $1,123 | +12.3% |
| 2 years | $30.37 | +51.8% | $1.75 | $1,575 | +57.5% |
| 3 years | $25.47 | +80.9% | $2.68 | $1,914 | +91.4% |
| 5 years | $23.28 | +98.0% | $3.93 | $2,148 | +114.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FAST does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.